Cash flow Hyperion DeFi, Inc.

Equities

HYPD

US30234E2037

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-07-16 pm EDT			5-day change	1st Jan Change
15.97 ^USD	+23.94%		+48.01%	+36.73%

Jul. 02	Eyenovia, Inc. will Change its Name to Hyperion DeFi, Inc	CI
Jul. 02	Eyenovia, Inc. will Change its Ticker to HYPD from EYEN	CI

db4dc003bd0002897f.EZn6kuUAsSW60PVguKry7SyI1QNv6KYoT6NOr9svJBE.XM2ApIxO-3PthoIWi-6ZoEbbukQ2oPJcKNl7-Ld-cXh6wbPinEPAVc6nuA

Published financial data: HYPERION DEFI, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	2M	14M	-	3.79K	57.34K
Total Revenues	2M	14M	-	3.79K	57.34K
Cost of Goods Sold, Total	800K	1.6M	-	3.79K	8.79M
Gross Profit	1.2M	12.4M	-	0	-8.73M
Selling General & Admin Expenses, Total	7.79M	10.86M	14.53M	13.87M	15.17M
R&D Expenses	13.2M	14.44M	12.38M	11.53M	13.63M
Other Operating Expenses, Total	20.99M	25.3M	26.91M	25.41M	28.8M
Operating Income	-19.79M	-12.9M	-26.91M	-25.41M	-37.53M
Interest Expense, Total	-17.04K	-388K	-1.38M	-2.37M	-2.48M
Interest And Investment Income	26.4K	2.52K	83.33K	694K	254K
Net Interest Expenses	9.36K	-385K	-1.3M	-1.68M	-2.23M
Other Non Operating Income (Expenses)	-	47.18K	197K	-176K	-90.6K
EBT, Excl. Unusual Items	-19.78M	-13.24M	-28.01M	-27.26M	-39.85M
Asset Writedown	-	-	-	-	-11.21M
Other Unusual Items	10K	463K	-	-	1.24M
EBT, Incl. Unusual Items	-19.77M	-12.78M	-28.01M	-27.26M	-49.82M
Earnings From Continuing Operations	-19.77M	-12.78M	-28.01M	-27.26M	-49.82M
Net Income to Company	-19.77M	-12.78M	-28.01M	-27.26M	-49.82M
Net Income - (IS)	-19.77M	-12.78M	-28.01M	-27.26M	-49.82M
Net Income to Common Incl Extra Items	-19.77M	-12.78M	-28.01M	-27.26M	-49.82M
Net Income to Common Excl. Extra Items	-19.77M	-12.78M	-28.01M	-27.26M	-49.82M
Per Share Items
Net EPS - Basic	-75.12	-38.83	-66.59	-53.15	-59.81
Basic EPS - Continuing Operations	-75.12	-38.83	-66.59	-53.15	-59.81
Basic Weighted Average Shares Outstanding	263K	329K	421K	513K	833K
Net EPS - Diluted	-75.12	-39.2	-66.59	-53.15	-59.81
Diluted EPS - Continuing Operations	-75.12	-39.2	-66.59	-53.15	-59.81
Diluted Weighted Average Shares Outstanding	263K	329K	421K	513K	833K
Normalized Basic EPS	-46.97	-25.15	-41.62	-33.22	-29.9
Normalized Diluted EPS	-46.97	-25.15	-41.62	-33.22	-29.9
Supplemental Items
EBITDA	-19.69M	-12.68M	-26.6M	-24.62M	-36.4M
EBITA	-19.79M	-12.9M	-26.91M	-25.41M	-37.53M
EBIT	-19.79M	-12.9M	-26.91M	-25.41M	-37.53M
EBITDAR	-19.63M	-12.62M	-25.23M	-22.78M	-35.08M
Normalized Net Income	-12.36M	-8.28M	-17.51M	-17.04M	-24.91M
Interest on Long-Term Debt	17.04K	317K	1.38M	2.37M	2.48M
Supplemental Operating Expense Items
General and Administrative Expenses	7.73M	10.79M	13.15M	12.03M	12.77M
Research And Development Expense From Footnotes	13.26M	14.51M	13.38M	12.98M	14.46M
Net Rental Expense, Total	59.72K	64.85K	1.38M	1.84M	1.32M
Imputed Operating Lease Interest Expense	-	52.84K	1.76M	2.67M	1.92M
Imputed Operating Lease Depreciation	-	12.01K	-383K	-826K	-600K
Stock-Based Comp., R&D Exp. (Total)	1.35M	1.61M	1.81M	839K	623K
Stock-Based Comp., G&A Exp. (Total)	1.13M	1.27M	1.96M	1.66M	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	1.08M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	2.48M	2.89M	3.77M	2.5M	1.7M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	28.37M	19.46M	22.86M	14.85M	2.12M
Total Cash And Short Term Investments	28.37M	19.46M	22.86M	14.85M	2.12M
Accounts Receivable, Total	2.97M	1.81M	1.18M	124K	24.83K
Other Receivables	152K	344K	661K	501K	289K
Total Receivables	3.12M	2.15M	1.84M	625K	314K
Inventory	-	-	-	110K	-
Prepaid Expenses	233K	387K	501K	444K	280K
Other Current Assets, Total	1.67M	4.52K	2.43M	4.68M	52.65K
Total Current Assets	33.39M	22M	27.64M	20.71M	2.77M
Gross Property Plant And Equipment	573K	1.6M	3.22M	6.46M	3.27M
Accumulated Depreciation	-177K	-328K	-636K	-1.42M	-2.55M
Net Property Plant And Equipment	396K	1.27M	2.59M	5.04M	718K
Other Intangibles, Total	-	-	-	2.12M	-
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	119K	8.39M	807K	909K	182K
Total Assets	33.91M	31.66M	31.04M	28.78M	3.67M
Liabilities
Accounts Payable, Total	1.46M	1.61M	1.43M	1.75M	2.2M
Accrued Expenses, Total	2.58M	2.33M	2.1M	1.81M	341K
Current Portion of Long-Term Debt	97.54K	7.15M	349K	5.33M	9.95M
Current Portion of Leases	-	-	485K	501K	575K
Other Current Liabilities	14.06M	81.09K	148K	135K	2.98M
Total Current Liabilities	18.2M	11.17M	4.51M	9.53M	16.05M
Long-Term Debt	366K	-	8.38M	8.96M	-
Long-Term Leases	-	-	908K	1.29M	718K
Other Non Current Liabilities	38.68K	19.95K	-	-	-
Total Liabilities	18.6M	11.19M	13.8M	19.78M	16.76M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	2.5K	2.84K	3.67K	4.56K	151
Additional Paid In Capital	92.74M	111M	135M	154M	182M
Retained Earnings	-77.44M	-90.22M	-118M	-145M	-195M
Total Common Equity	15.3M	20.47M	17.23M	9M	-13.1M
Total Equity	15.3M	20.47M	17.23M	9M	-13.1M
Total Liabilities And Equity	33.91M	31.66M	31.04M	28.78M	3.67M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	320K	396K	475K	592K	2.83M
ECS Total Common Shares Outstanding	312K	355K	458K	569K	1.51M
Book Value / Share	49.01	57.6	37.6	15.8	-8.69
Tangible Book Value	15.3M	20.47M	17.23M	6.88M	-13.1M
Tangible Book Value Per Share	49.01	57.6	37.6	12.08	-8.69
Total Debt	463K	7.15M	10.12M	16.08M	11.24M
Net Debt	-27.91M	-12.31M	-12.74M	1.23M	9.12M
Debt Equivalent Oper. Leases	478K	519K	11.01M	14.75M	10.56M
Account Code - Inventory Valuation	3	-	3	5	5
Inventories - Raw Materials, Total	-	-	-	79.12K	-
Inventories - Finished Goods, Total	-	-	-	30.68K	-
Machinery, Total	436K	1.11M	1.36M	3.04M	4.01M
Full Time Employees	31	43	41	57	13
Part Time Employees	3	2	-	-	1

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-19.77M	-12.78M	-28.01M	-27.26M	-49.82M
Depreciation & Amortization - CF	95.42K	222K	307K	783K	1.13M
Depreciation & Amortization, Total	95.42K	222K	307K	783K	1.13M
Amortization of Deferred Charges, Total - (CF)	-	68.38K	412K	682K	759K
(Gain) Loss From Sale Of Asset	-	-55.19K	-	-	-
Asset Writedown & Restructuring Costs	-	-	209K	-	11.21M
Stock-Based Compensation (CF)	2.48M	2.89M	3.77M	2.5M	1.7M
Other Operating Activities, Total	-	-515K	475K	942K	5.24M
Change In Inventories	-	-	-	-122K	-
Change In Accounts Payable	-79.69K	126K	-186K	325K	447K
Change in Other Net Operating Assets	10.89M	-10.83M	-2.08M	-1.68M	-786K
Cash from Operations	-6.38M	-20.87M	-25.11M	-23.84M	-30.12M
Capital Expenditure	-261K	-1.62M	-875K	-2.85M	-161K
Sale of Property, Plant, and Equipment	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-1.12M	-
Cash from Investing	-261K	-1.62M	-875K	-3.97M	-161K
Long-Term Debt Issued, Total	463K	7.5M	-	-	-
Total Debt Issued	463K	7.5M	-	-	-
Long-Term Debt Repaid, Total	-475K	-705K	-8.18M	-609K	-5.51M
Total Debt Repaid	-475K	-705K	-8.18M	-609K	-5.51M
Issuance of Common Stock	22.69M	15.11M	24.7M	17.59M	24.38M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-1.81M	-450K	4.98M	2.81M	-1.32M
Cash from Financing	20.86M	21.46M	21.51M	19.79M	17.55M
Net Change in Cash	14.22M	-1.03M	-4.47M	-8.01M	-12.73M
Supplemental Items
Cash Interest Paid	13.97K	227K	316K	1.69M	1.62M
Levered Free Cash Flow	305K	-18.35M	-16.65M	-18.43M	-14.54M
Unlevered Free Cash Flow	315K	-18.17M	-16.2M	-17.63M	-13.75M
Change In Net Working Capital	-10.37M	11.6M	2.58M	1.06M	-7.03M
Net Debt Issued / Repaid	-11.86K	6.79M	-8.18M	-609K	-5.51M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-50.89	-24.6	-53.66	-53.09	-144.58
Return on Total Capital	-89.93	-37.18	-61.19	-60.56	-201.99
Return On Equity %	-146.2	-71.45	-148.6	-207.83	2.43K
Return on Common Equity	-146.2	-71.45	-148.6	-207.83	2.43K
Margin Analysis
Gross Profit Margin %	60	88.57	-	0	-15.23K
SG&A Margin	389.26	77.56	-	366K	26.45K
EBITDA Margin %	-984.69	-90.59	-	-650K	-63.49K
EBITA Margin %	-989.46	-92.17	-	-671K	-65.46K
EBIT Margin %	-989.46	-92.17	-	-671K	-65.46K
Income From Continuing Operations Margin %	-988.49	-91.27	-	-720K	-86.89K
Net Income Margin %	-988.49	-91.27	-	-720K	-86.89K
Net Avail. For Common Margin %	-988.49	-91.27	-	-720K	-86.89K
Normalized Net Income Margin	-618.12	-59.11	-	-450K	-43.44K
Levered Free Cash Flow Margin	15.24	-131.06	-	-487K	-25.37K
Unlevered Free Cash Flow Margin	15.77	-129.82	-	-465K	-23.98K
Asset Turnover
Asset Turnover	0.08	0.43	-	0	0
Fixed Assets Turnover	6.38	16.79	-	0	0.02
Receivables Turnover (Average Receivables)	-	5.87	-	0.01	0.77
Short Term Liquidity
Current Ratio	1.83	1.97	6.13	2.17	0.17
Quick Ratio	1.73	1.93	5.48	1.62	0.15
Operating Cash Flow to Current Liabilities	-0.35	-1.87	-5.56	-2.5	-1.88
Days Sales Outstanding (Average Receivables)	-	62.19	-	63.02K	474.48
Average Days Payable Outstanding	686.94	350.83	-	-	-
Long Term Solvency
Total Debt/Equity	3.03	34.94	58.74	178.69	-85.84
Total Debt / Total Capital	2.94	25.89	37	64.12	-606.1
LT Debt/Equity	2.39	-	53.9	113.9	-5.48
Long-Term Debt / Total Capital	2.32	-	33.96	40.87	-38.69
Total Liabilities / Total Assets	54.86	35.35	44.47	68.73	457.06
EBIT / Interest Expense	-1.16K	-33.28	-19.5	-10.71	-15.11
EBITDA / Interest Expense	-1.16K	-32.71	-18.28	-9.6	-14.12
(EBITDA - Capex) / Interest Expense	-1.17K	-36.88	-18.91	-10.8	-14.19
Total Debt / EBITDA	-0.02	-0.56	-0.4	-0.71	-0.32
Net Debt / EBITDA	1.42	0.97	0.51	-0.05	-0.26
Total Debt / (EBITDA - Capex)	-0.02	-0.5	-0.39	-0.63	-0.32
Net Debt / (EBITDA - Capex)	1.4	0.86	0.49	-0.05	-0.26
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	600	-	-	1.41K
Gross Profit, 1 Yr. Growth %	-	933.33	-	-	71.39K
EBITDA, 1 Yr. Growth %	-7.51	-35.6	107.86	-7.45	47.84
EBITA, 1 Yr. Growth %	-7.13	-34.79	106.69	-5.59	47.72
EBIT, 1 Yr. Growth %	-7.13	-34.79	106.69	-5.59	47.72
Earnings From Cont. Operations, 1 Yr. Growth %	-6.56	-35.36	119.21	-2.68	82.75
Net Income, 1 Yr. Growth %	-6.56	-35.36	119.21	-2.68	82.75
Normalized Net Income, 1 Yr. Growth %	-6.51	-33.05	111.54	-2.68	46.18
Diluted EPS Before Extra, 1 Yr. Growth %	-36.31	-47.87	69.88	-20.19	12.53
Accounts Receivable, 1 Yr. Growth %	-	-39.14	-34.42	-89.54	-79.95
Net Property, Plant and Equip., 1 Yr. Growth %	71.94	220.71	103.48	94.88	-85.75
Total Assets, 1 Yr. Growth %	130.7	-6.63	-1.97	-7.27	-87.26
Tangible Book Value, 1 Yr. Growth %	30.35	33.73	-15.79	-60.1	-290.45
Common Equity, 1 Yr. Growth %	30.35	33.73	-15.79	-47.78	-245.53
Cash From Operations, 1 Yr. Growth %	-66.26	226.97	20.27	-5.05	26.36
Capital Expenditures, 1 Yr. Growth %	56.78	519.51	-45.95	225.53	-94.33
Levered Free Cash Flow, 1 Yr. Growth %	-102.72	-6.12K	-9.59	10.64	-21.07
Unlevered Free Cash Flow, 1 Yr. Growth %	-102.81	-5.86K	-11.2	8.77	-21.99
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-98.36	-
EBITDA, 2 Yr. CAGR %	6.89	-22.83	16.23	38.7	16.97
EBITA, 2 Yr. CAGR %	7.09	-22.18	16.62	39.69	18.09
EBIT, 2 Yr. CAGR %	7.09	-22.18	16.62	39.69	18.09
Earnings From Cont. Operations, 2 Yr. CAGR %	7.05	-22.28	19.03	46.06	33.36
Net Income, 2 Yr. CAGR %	7.05	-22.28	19.03	46.06	33.36
Normalized Net Income, 2 Yr. CAGR %	7.07	-20.89	19	43.48	19.28
Diluted EPS Before Extra, 2 Yr. CAGR %	-28.18	-42.35	-5.9	16.44	-5.23
Accounts Receivable, 2 Yr. CAGR %	-	-	-36.82	-73.81	-85.52
Net Property, Plant and Equip., 2 Yr. CAGR %	228.47	134.82	155.46	99.14	-47.3
Total Assets, 2 Yr. CAGR %	30.15	46.77	-4.33	-4.66	-65.62
Tangible Book Value, 2 Yr. CAGR %	-4.77	32.03	6.12	-42.04	-12.83
Common Equity, 2 Yr. CAGR %	-4.77	32.03	6.12	-33.69	-12.83
Cash From Operations, 2 Yr. CAGR %	-30.22	5.04	98.3	6.86	9.53
Capital Expenditures, 2 Yr. CAGR %	205.97	211.65	82.98	32.64	-57.04
Levered Free Cash Flow, 2 Yr. CAGR %	-78.71	27.95	639.26	0.01	-6.55
Unlevered Free Cash Flow, 2 Yr. CAGR %	-78.34	27.34	616.77	-1.72	-7.88
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-87.63	-84
Gross Profit, 3 Yr. CAGR %	-	-	-	-	-11.02
EBITDA, 3 Yr. CAGR %	56.82	-9.72	7.7	7.73	41.68
EBITA, 3 Yr. CAGR %	56.81	-9.23	8.09	8.69	42.32
EBIT, 3 Yr. CAGR %	56.81	-9.23	8.09	8.69	42.32
Earnings From Cont. Operations, 3 Yr. CAGR %	56.78	-9.52	9.81	11.3	57.39
Net Income, 3 Yr. CAGR %	56.78	-9.52	9.81	11.3	57.39
Normalized Net Income, 3 Yr. CAGR %	56.81	-8.44	9.81	11.29	44.38
Diluted EPS Before Extra, 3 Yr. CAGR %	-24.57	-35.44	-17.35	-10.92	15.12
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-65.31	-76.04
Net Property, Plant and Equip., 3 Yr. CAGR %	142.02	225.86	123.87	133.42	-17.33
Total Assets, 3 Yr. CAGR %	81.8	16.51	28.29	-5.32	-51.25
Tangible Book Value, 3 Yr. CAGR %	44.33	6.64	13.65	-23.41	-13.83
Common Equity, 3 Yr. CAGR %	44.33	6.64	13.65	-16.22	-13.83
Cash From Operations, 3 Yr. CAGR %	10.51	16.77	9.89	55.14	13
Capital Expenditures, 3 Yr. CAGR %	194.45	287.08	73.79	121.72	-53.62
Levered Free Cash Flow, 3 Yr. CAGR %	-51.59	39.74	14.11	292.49	-7.58
Unlevered Free Cash Flow, 3 Yr. CAGR %	-51.03	39.29	13.07	282.32	-9
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	35.83	29.2	39.11	7.39	11.32
EBITA, 5 Yr. CAGR %	35.9	29.56	39.29	8.04	11.99
EBIT, 5 Yr. CAGR %	35.9	29.56	39.29	8.04	11.99
Earnings From Cont. Operations, 5 Yr. CAGR %	35.89	29.32	40.42	9.58	18.68
Net Income, 5 Yr. CAGR %	35.89	29.32	40.42	9.58	18.68
Normalized Net Income, 5 Yr. CAGR %	35.9	30.24	40.42	9.58	13.5
Diluted EPS Before Extra, 5 Yr. CAGR %	-12.99	-20.66	-17.57	-18.26	-12.7
Net Property, Plant and Equip., 5 Yr. CAGR %	98.46	96.68	147.31	167.6	25.52
Total Assets, 5 Yr. CAGR %	64.46	55.94	40.63	7.53	-24.24
Tangible Book Value, 5 Yr. CAGR %	44.87	46.74	27.62	-16.44	2.21
Common Equity, 5 Yr. CAGR %	44.87	46.74	27.62	-11.82	2.21
Cash From Operations, 5 Yr. CAGR %	10.75	45.48	39.62	12.7	9.75
Capital Expenditures, 5 Yr. CAGR %	120.9	106.49	143.43	152.2	-0.63
Levered Free Cash Flow, 5 Yr. CAGR %	-	57.02	44.04	22.34	5.35
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	56.72	43.25	21.25	4.17